Whitepapers
The dangers of blue light: what is it and how can we protect against its threat?
A growing body of medical research is beginning to focus on the role played by harmful blue light in damaging the eye, leading to conditions like age-related macular degeneration (AMD).
This has been prompted by two global factors: an ageing population and a younger generation making regular, heavy use of blue light-emitting technology.
In this whitepaper we examine the effects of blue light, the eye’s natural resistance to it, and how that resistance can be bolstered.
Age-related macular degeneration: the case for early screening
Our whitepaper explores the development of AMD and helps you to understand the key risk factors. Our analysis spans non-modifiable risk factors such as family history and genetic, as well as modifiable factors like smoking, diet and BMI.
Read our paper for insights into:
- The academic case for targeted screening
- Lifestyle factors affecting AMD development
- Understanding wet and dry AMD
- How ophthalmologists can raise awareness of AMD
The use of MPS II as part of a macular screening programme
Prevention is better than intervention
This whitepaper outlines pragmatic guidelines for a coherent strategy around the prevention and management of age-related macular degeneration (AMD).
- Written by Dr. Scott Mackie, a Consultant Ophthalmologist.
